Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids
Compose a Response to This Article
Other responses
No responses have been published for this article.
